NASDAQ:AMPH
Amphastar Pharmaceuticals Stock News
$42.43
+0.220 (+0.521%)
At Close: May 09, 2024
Needham & Company LLC Reiterates Hold Rating for Amphastar Pharmaceuticals (NASDAQ:AMPH)
09:18am, Wednesday, 29'th Apr 2020
Amphastar Pharmaceuticals (NASDAQ:AMPH)‘s stock had its “hold” rating reaffirmed by research analysts at Needham & Company LLC in a report issued on Monday, AnalystRatings.com reports. Several o
Clearside Biomedical (CLSD) Gets a Hold Rating from Needham
06:24pm, Tuesday, 28'th Apr 2020
Needham analyst Serge Belanger maintained a Hold rating on Clearside Biomedical (CLSD) today. The company's shares closed last Tuesday at $1.98. According
Clearside Biomedical (CLSD) Gets a Hold Rating from Needham
06:24pm, Tuesday, 28'th Apr 2020
Needham analyst
Serge Belanger
maintained a
Hold
rating on Clearside Biomedical (
CLSD
–
Research Report
) today. The company’s shares closed last Tuesday at $1.98.
According to
TipRanks.com
, Bel
Needham Reaffirms Their Hold Rating on Amphastar Pharmaceuticals (AMPH)
01:32pm, Monday, 27'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Hold rating on Amphastar Pharmaceuticals (AMPH). The company's shares closed last
Needham Reaffirms Their Hold Rating on Amphastar Pharmaceuticals (AMPH)
01:32pm, Monday, 27'th Apr 2020
In a report released today,
Serge Belanger
from Needham maintained a
Hold
rating on Amphastar Pharmaceuticals (
AMPH
–
Research Report
). The company’s shares closed last Monday at $17.10.
Accordi
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Shares Sold by Nuveen Asset Management LLC
10:54am, Monday, 27'th Apr 2020
Nuveen Asset Management LLC lowered its stake in shares of Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) by 54.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. Th
BRIEF-Amphastar Pharmaceuticals gets FDA Approval For Epinephrine Injection
10:07am, Monday, 27'th Apr 2020
Amphastar Pharmaceuticals Inc:
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
10:00am, Monday, 27'th Apr 2020
Amphastar’s newly approved drug product was determined by the FDA to be therapeutically equivalent to Adrenalin® (Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial) distributed in th
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
10:00am, Monday, 27'th Apr 2020
RANCHO CUCAMONGA, Calif., April 27, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) (“Amphastar”), today announces that the...
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Expected to Announce Quarterly Sales of $81.13 Million
05:32am, Monday, 27'th Apr 2020
Brokerages forecast that Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) will announce sales of $81.13 million for the current quarter, Zacks Investment Research reports. Three analysts have provided esti
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP ...
12:00am, Monday, 27'th Apr 2020Collegium Pharmaceutical (COLL) Gets a Buy Rating from Needham
12:28pm, Friday, 24'th Apr 2020
Needham analyst Serge Belanger assigned a Buy rating to Collegium Pharmaceutical (COLL) today and set a price target of $38.00. The company's shares
Collegium Pharmaceutical (COLL) Gets a Buy Rating from Needham
12:28pm, Friday, 24'th Apr 2020
Needham analyst Serge Belanger assigned a Buy rating to Collegium Pharmaceutical (COLL – Research Report) today and set a price
Needham Thinks Aerie Pharma's Stock is Going to Recover
12:18pm, Friday, 24'th Apr 2020
Needham analyst Serge Belanger assigned a Buy rating to Aerie Pharma (AERI) today and set a price target of $40.00. The company's shares closed last
Needham Thinks Aerie Pharma’s Stock is Going to Recover
12:17pm, Friday, 24'th Apr 2020
Needham analyst
Serge Belanger
assigned a
Buy
rating to Aerie Pharma (
AERI
–
Research Report
) today and set a price target of
$40.00
. The company’s shares closed last Thursday at $14.01, close
